E. Smit

发表论文 14 篇 · 总被引 348 次 · h-index 10

代表论文

• DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. (2019 · Lung Cancer · 被引 63)
• PHASE II ACTIVITY OF THE HSP90 INHIBITOR AUY922 IN PATIENTS WITH ALK-REARRANGED (ALK plus ) OR EGFR-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) (2012 · 被引 55)
• Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC. (2024 · Annals of Oncology · 被引 48)
• Breast cancer, early stage (2012 · 被引 45)
• Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC). (2018 · Annals of Oncology · 被引 42)
• Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). (2019 · Lung Cancer · 被引 32)